Literature DB >> 18846074

Enhancing immunity to HIV through APOBEC.

Reuben S Harris1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18846074     DOI： 10.1038/nbt1008-1089

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  26 in total

1.  Oxidative Reactivities of 2-Furylquinolines: Ubiquitous Scaffolds in Common High-Throughput Screening Libraries.

Authors:  Margaret E Olson; Daniel Abate-Pella; Angela L Perkins; Ming Li; Michael A Carpenter; Anurag Rathore; Reuben S Harris; Daniel A Harki
Journal:  J Med Chem       Date:  2015-09-11       Impact factor: 7.446

2.  Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.

Authors:  Judd F Hultquist; Reuben S Harris
Journal:  Future Virol       Date:  2009-11-01       Impact factor: 1.831

3.  Damage control: how HIV survives the editor APOBEC3G.

Authors:  J Ludovic Croxford; Stephan Gasser
Journal:  Nat Immunol       Date:  2011-09-20       Impact factor: 25.606

Review 4.  The restriction factors of human immunodeficiency virus.

Authors:  Reuben S Harris; Judd F Hultquist; David T Evans
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

5.  First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G.

Authors:  Ming Li; Shivender M D Shandilya; Michael A Carpenter; Anurag Rathore; William L Brown; Angela L Perkins; Daniel A Harki; Jonathan Solberg; Derek J Hook; Krishan K Pandey; Michael A Parniak; Jeffrey R Johnson; Nevan J Krogan; Mohan Somasundaran; Akbar Ali; Celia A Schiffer; Reuben S Harris
Journal:  ACS Chem Biol       Date:  2012-01-17       Impact factor: 5.100

Review 6.  Human endogenous retroviruses and cancer: causality and therapeutic possibilities.

Authors:  Christina S Mullins; Michael Linnebacher
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

Review 7.  The APOBEC3 family of retroelement restriction factors.

Authors:  Eric W Refsland; Reuben S Harris
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

8.  Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.

Authors:  Andrew E Armitage; Koen Deforche; John J Welch; Kristel Van Laethem; Ricardo Camacho; Andrew Rambaut; Astrid K N Iversen
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

Review 9.  APOBEC Enzymes as Targets for Virus and Cancer Therapy.

Authors:  Margaret E Olson; Reuben S Harris; Daniel A Harki
Journal:  Cell Chem Biol       Date:  2017-11-16       Impact factor: 8.116

10.  Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance.

Authors:  Patric Jern; Rebecca A Russell; Vinay K Pathak; John M Coffin
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.